Lab21 on acquisition trail

Lab21, a Cambridge-based healthcare diagnostics company, has acquired Plasmatec Laboratory Products, a Dorset-based manufacturer and distributor of in vitro diagnostic tests. 


Lab21, a Cambridge-based healthcare diagnostics company, has acquired Plasmatec Laboratory Products, a Dorset-based manufacturer and distributor of in vitro diagnostic tests. 

Lab21, a Cambridge-based healthcare diagnostics company, has acquired Plasmatec Laboratory Products, a Dorset-based manufacturer and distributor of in vitro diagnostic tests.

The deal comes shortly after the acquisition of Biotec Laboratories. Graham Mullis, CEO of Lab21, commented: “Plasmatec will continue to be based in Dorset but there will be significant cross-selling opportunities within Lab21’s enlarged diagnostic products division. This acquisition follows the purchase earlier this year of Biotec Laboratories Ltd and underlines the momentum of our buy-and-build strategy.”

Martin Shaw, founder and managing director of Plasmatec, said: “Plasmatec is well placed to add to Lab21’s growing product portfolio and offers particular expertise in the Middle East and South American markets.”

Nick Britton

Nick Britton

Nick was the Managing Editor for growthbusiness.co.uk when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary...

Related Topics